Associated Papers
Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail.
Ong M et al.
British Journal of Cancer, 2014
PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis.
Dong Y et al.
Human Pathology, 2012
[Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology, 2011
The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors.
Stehr H et al.
Molecular Cancer, 2011
21575214 (PubMed )
Supplement: 1476-4598-10-54-S3.XLS › mutations.txt
PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches.
Ligresti G et al.
Cell Cycle (georgetown, Tex.), 2009
PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
Schönleben F et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2006
Select a paper to view details